BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17420089)

  • 1. Editorial comment on: Platelet count and preoperative haemoglobin do not significantly increase the performance of established predictors of renal cell carcinoma-specific mortality.
    Bex A
    Eur Urol; 2007 Nov; 52(5):1436-7. PubMed ID: 17420089
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet count and preoperative haemoglobin do not significantly increase the performance of established predictors of renal cell carcinoma-specific mortality.
    Karakiewicz PI; Trinh QD; Lam JS; Tostain J; Pantuck AJ; Belldegrun AS; Patard JJ
    Eur Urol; 2007 Nov; 52(5):1428-36. PubMed ID: 17420085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial comment.
    Maranchie JK
    J Urol; 2010 Feb; 183(2):492. PubMed ID: 20006863
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial comment.
    Campbell SC; Lane BR
    J Urol; 2010 Feb; 183(2):485; discussion 485. PubMed ID: 20006871
    [No Abstract]   [Full Text] [Related]  

  • 5. High platelet count multiplies risk following renal cell carcinoma treatment.
    Urol Nurs; 2001 Jun; 21(3):224-5. PubMed ID: 11998657
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial comment.
    Uzzo RG
    J Urol; 2009 Nov; 182(5):2171. PubMed ID: 19758642
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial comment.
    Klatte T
    J Urol; 2009 Dec; 182(6):2606. PubMed ID: 19836796
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial comment.
    Keeley FX; Minervini A
    Urology; 2009 Sep; 74(3):640-1; author reply 642. PubMed ID: 19716920
    [No Abstract]   [Full Text] [Related]  

  • 9. Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score.
    Iimura Y; Saito K; Fujii Y; Kumagai J; Kawakami S; Komai Y; Yonese J; Fukui I; Kihara K
    J Urol; 2009 Mar; 181(3):1004-12; discussion 1012. PubMed ID: 19150550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.
    Kanao K; Mizuno R; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Nakashima J; Oya M
    J Urol; 2009 Feb; 181(2):480-5; discussion 485. PubMed ID: 19100568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial comment.
    Singer EA; Srinivasan R; Bratslavsky G
    J Urol; 2011 Jan; 185(1):66. PubMed ID: 21074200
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial comment.
    Pomara G; Francesca F
    Urology; 2011 May; 77(5):1146; author reply 1146-7. PubMed ID: 21539964
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic impact of postoperative C-reactive protein level in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy.
    Tatokoro M; Saito K; Iimura Y; Fujii Y; Kawakami S; Kihara K
    J Urol; 2008 Aug; 180(2):515-9. PubMed ID: 18550105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of platelet count in patients with renal cell carcinoma.
    Erdemir F; Kilciler M; Bedir S; Ozgok Y; Coban H; Erten K
    Urol Int; 2007; 79(2):111-6. PubMed ID: 17851278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial comment on: Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.
    Eggener S
    Eur Urol; 2010 Mar; 57(3):472. PubMed ID: 19359087
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial comment on: Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.
    Russo P
    Eur Urol; 2010 Mar; 57(3):472-3. PubMed ID: 19359086
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Absolute preoperative C-reactive protein predicts metastasis and mortality in the first year following potentially curative nephrectomy for clear cell renal cell carcinoma: T. V. Johnson, A. Abbasi, A. Owen-Smith, A. Young, K. Ogan, J. Pattaras, P. Nieh, F. F. Marshall and V. A. Master J Urol 2010; 183: 480-485.
    Canda AE
    J Urol; 2010 Oct; 184(4):1570-1; author reply 1571. PubMed ID: 20728182
    [No Abstract]   [Full Text] [Related]  

  • 18. Functional and oncological outcomes of partial nephrectomy of solitary kidneys.
    La Rochelle J; Shuch B; Riggs S; Liang LJ; Saadat A; Kabbinavar F; Pantuck A; Belldegrun A
    J Urol; 2009 May; 181(5):2037-42; discussion 2043. PubMed ID: 19298974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial comment.
    Russo P
    Urology; 2010 Feb; 75(2):275-6; author reply 276. PubMed ID: 20152477
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial comment.
    Russo P
    Urology; 2009 May; 73(5):1082. PubMed ID: 19394510
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.